Cerecin
PrivateLast Round
Pre Seed
May 9, 2024
Total Funding Raised
$46M
Company Overview
Cerecin operates in Healthcare & Life Sciences and is based in Broomfield, Colorado. Its latest recorded funding round was a Series B Extension round in October 2022.
Cerecin is a clinical-stage biotechnology company that develops therapeutics targeting the metabolic basis of central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging, Precision Medicine
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cerecin Comparables
Compare Cerecin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| T3D Therapeutics, Inc. | 78% | |
| AriBio | 70% | |
| Nestlé | 64% |
For institutional investors. Book with your work email.
Cerecin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 9, 2024 | ||||
| Series B Extension | Oct 3, 2022 | ||||
| Series B | Oct 19, 2021 | ||||
| VC Round | Oct 4, 2018 | ||||
| VC Round | Jul 18, 2012 | ||||
Series A | Oct 5, 2004 |
For institutional investors. Book with your work email.
Cerecin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wilmar Ventures | Pre Seed, VC Round |
| Hanwha Investment & Securities | Pre Seed |
| BNK Securities | Pre Seed |
| Linea Investment | Series A |
| IBK Capital | Series B |
| KNT Investment | Series B Extension |
| KB Securities | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 9, 2024
$29M round with participation from Nestlé and Wilmar Ventures.
- Oct 3, 2022
Led by SK Securities and KNT Investment.
For institutional investors. Book with your work email.
Cerecin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cerecin's valuation, stock price, and market status.
Is Cerecin a public or private company?
Cerecin is a private company.
What is the current stock price of Cerecin?
Cerecin is a private company, so its shares have no public market price. Caplight tracks Cerecin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cerecin worth (valuation)?
Valuation information for Cerecin is not publicly available.
Can I buy Cerecin stock?
Cerecin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cerecin's last funding round?
Cerecin's most recent funding round was Pre Seed on May 9, 2024.
Who are the main investors in Cerecin?
Key investors in Cerecin include Wilmar Ventures, KNT Investment, Inventages, Hana Securities, SK Securities.
Will Cerecin IPO soon?
No public IPO plans have been announced for Cerecin.
How can I track Cerecin secondary market activity?
Caplight tracks bids, offers, and trades in Cerecin's shares on secondary markets.